US · biotech · healthcare · pharmaceutical
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series B · Oct 2024 · $225M
General Atlantic lead
Reported by Crunchbase News · SEC filing: $226M sold under the offering, first sale Oct 2024
Missing a round, or an investor who was in one? Tell us.